Sector consensus Marinus Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-09-13 pm EDT			5-day change	1st Jan Change
1.500 ^USD	+7.91%		+7.14%	-86.20%

Aug. 14	Ladenburg Thalmann Downgrades Marinus Pharmaceuticals to Neutral From Buy	MT
Aug. 13	Transcript : Marinus Pharmaceuticals, Inc., Q2 2024 Earnings Call, Aug 13, 2024

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
MARINUS PHARMACEUTICALS, INC.	7.000	+366.67%	8
ELI LILLY AND COMPANY	995.42	+7.76%	25
NOVO NORDISK A/S	967.54	+5.34%	26
JOHNSON & JOHNSON	171.32	+3.51%	22
ABBVIE INC.	196.30	+1.08%	27
MERCK & CO., INC.	139.03	+19.99%	26
ROCHE HOLDING AG	297.08	+11.85%	19
ASTRAZENECA PLC	183.99	+17.35%	20
NOVARTIS AG	116.54	+0.65%	20
AMGEN INC.	324.71	-2.33%	24
PFIZER, INC.	33.23	+13.54%	22
SANOFI	112.17	+8.49%	22
GILEAD SCIENCES, INC.	83.54	+0.88%	27
BRISTOL-MYERS SQUIBB COMPANY	53.34	+8.57%	21
GSK PLC	19.68	+20.47%	21
CHUGAI PHARMACEUTICAL CO., LTD	6,663.33	-0.84%	15
DAIICHI SANKYO CO., LTD.	6,512.50	+26.83%	16
HALEON PLC	3.865	-1.67%	17
TAKEDA PHARMACEUTICAL COMPANY LIMITED	4,768.83	+15.27%	18
Average	1,139.44	+27.55%	21
Weighted average by Cap.	718.17	+7.80%	23